No fees unless we win.
Get a free consultation
8 Reviews
5.0
★★★★★

Johnson & Johnson Agrees to $2.2 Billion Settlement Over Risperdal

According to the New York Times, Johnson & Johnson has agreed to pay more than $2.2 billion in criminal and civil fines to settle accusations that it improperly promoted the antipsychotic drug, Risperdal, to older adults, children and people with developmental disabilities.

The Times reported that the agreement is the third-largest drug settlement in U.S. history, and the largest involving the marketing of an antipsychotic and anti-seizure drug to older dementia patients. The paper reported that the federal government has been in ongoing negotiations with pharmaceutical companies over illegally marketing antipsychotic drugs for nearly a decade.

The settlement will require the approval of a federal judge.  Eric H. Holder Jr., the United States attorney general, said in a statement that Johnson & Johnson’s practices “recklessly put at risk the health of some of the most vulnerable members of our society — including young children, the elderly and the disabled.”

According to the Times, through the settlement, Johnson & Johnson has agreed to plead guilty to a criminal misdemeanor and acknowledged that it improperly marketed Risperdal to older adults for unapproved uses. The settlement will resolve actions brought on by 45 states.

Risperdal has been linked to skin complications, hyperprolactinaemia and weight gain.

Our attorneys represent victims of dangerous medical devices and drugs like Risperdal. For more information about this or other defective medical drugs or devices, contact our experienced pharmaceutical drug and device attorneys by calling toll-free (888) 841-9623
today.

Zoll, Kranz & Borgess, LLC – Dangerous Medical Drug Attorneys

Published by:
Share
Picture of Michelle L. Kranz
Michelle L. Kranz

Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.

Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.

Additional Dangerous Drugs resources on our website:
All
FAQs
Injuries & Conditions
Legal Help
Other Resources
Settlements & Compensation
You can learn more about this topic by visiting any of our Risperdal Lawsuit pages listed below:
Is Breast Growth a Side Effect of Risperdal?
Johnson & Johnson Loses Risperdal Breast Growth Lawsuit
Risperdal Whistleblower Claims That J&J Used Compensation Plan to Promote Risperdal For Off-Label Usage
Do you have a case?

A serious injury can have life-altering results.

Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.

8 Reviews
5.0
★★★★★
Recovered damages
$35 Million+

Table of Contents

Practice Areas
About Zoll & Kranz, LLC

For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.

Do you believe you’re entitled to compensation?

Use our Instant Case Evaluator to find out in as little as 60 seconds!

Guides & Resources

Other Risperdal Lawsuit Resources

All
FAQs
Injuries & Conditions
Legal Help
Other Resources
Settlements & Compensation